# Aoxing Pharmaceutical Company, Inc. (AOXG)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/AOXG/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 19.8K | $ -14.0K | $ -107.7K | $ 102.9K | $ -5.5K |
| 2025 | $ 0 | $ 54.9K | N/A | N/A | N/A |
| 2024 | $ 0 | $ -15.6K | $ -15.6K | N/A | N/A |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -18.82 |
| Liabilities / Eq | -24.03 |
| Current Ratio | 0.96 |

## Debt coverage

| Indicator | Value |
| --- | --- |
| Gross Debt / Earnings | 5.04 |

## Other views

- [Metrics](https://sponda.capital/en/AOXG.md)
- [Charts](https://sponda.capital/en/AOXG/charts.md)
- [Compare](https://sponda.capital/en/AOXG/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.